Stoke TherapeuticsSTOK
那斯達克 · USD
32.86
-0.75
(-2.23%)
收盤 12/18 04:59 (UTC+8)
12/18 04:59 (UTC+8)
Stoke TherapeuticsSTOK
32.86
-0.75
(-2.23%)
財務數據
損益表
- -0.02
- 0.03
- 0.03
- 0.04
- 0.05
- 0.05
- 0.23
- 1.59
- 0.14
- 0.11
- -
- -
- -15.27
- 50.46
- 14.61
- 1.26
- 362.17
- 601.20
- -91.29
- -23.05
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 10,632 | 13,817 | 158,569 | 22,614 | 4,893 | 4,832 | 4,216 | 2,802 | 3,307 | -2,481 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 10,632 | 13,817 | 158,569 | 22,614 | 4,893 | 4,832 | 4,216 | 2,802 | 3,307 | -2,481 |
營業費用 | 53,723 | 41,117 | 47,329 | 36,267 | 34,898 | 34,174 | 32,588 | 32,388 | 30,541 | 30,781 |
研發費用 | 37,696 | 25,855 | 32,676 | 23,423 | 22,206 | 21,136 | 22,368 | 21,778 | 20,271 | 20,551 |
推銷及管理費用 | 16,027 | 15,262 | 14,653 | 12,844 | 12,692 | 13,038 | 10,220 | 10,610 | 10,270 | 10,230 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -43,091 | -27,300 | 111,240 | -13,653 | -30,005 | -29,342 | -28,372 | -29,586 | -27,234 | -33,262 |
其他收入及費用 | 2 | 29 | 28 | 201 | 28 | -48 | -428 | 41 | 41 | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -39,626 | -23,482 | 114,157 | -10,482 | -26,430 | -25,695 | -26,374 | -26,958 | -24,542 | -30,654 |
所得稅 | -1,278 | - | 1,278 | - | - | - | - | - | - | - |
稅後純益 | -38,348 | -23,482 | 112,879 | -10,482 | -26,430 | -25,695 | -26,374 | -26,958 | -24,542 | -30,654 |
基本每股稅後盈餘(元) | -0.65 | -0.40 | 1.95 | -0.18 | -0.47 | -0.46 | -0.57 | - | -0.55 | -0.69 |
稀釋每股稅後盈餘(元) | -0.65 | -0.40 | 1.90 | -0.17 | -0.46 | -0.45 | -0.57 | -0.60 | -0.55 | -0.69 |
基本平均股數(千股) | 58611.00 | 58353.00 | 57862.00 | 57029.00 | 56341.00 | 55765.00 | 46246.00 | - | 44266.00 | 44188.00 |
稀釋平均股數(千股) | 58611.00 | 58353.00 | 59398.00 | 57029.00 | 56341.00 | 55765.00 | 46246.00 | - | 44266.00 | 44188.00 |
還原基本每股稅後盈餘(元) | -0.65 | -0.40 | 1.95 | -0.18 | -0.47 | -0.46 | -0.57 | - | -0.55 | -0.69 |
還原稀釋每股稅後盈餘(元) | -0.65 | -0.40 | 1.90 | -0.17 | -0.46 | -0.45 | -0.57 | -0.60 | -0.55 | -0.69 |
還原基本平均股數(千股) | 58,611 | 58,353 | 57,862 | 57,029 | 56,341 | 55,765 | 46,246 | - | 44,266 | 44,188 |
還原稀釋平均股數(千股) | 58,611 | 58,353 | 59,398 | 57,029 | 56,341 | 55,765 | 46,246 | - | 44,266 | 44,188 |
EBITDA(千元) | -39,799 | -22,509 | 114,140 | -10,738 | -26,437 | -25,436 | -25,835 | -26,423 | -24,027 | -30,043 |